National trends in ambulatory asthma treatment, 1997-2009

Journal of General Internal Medicine

Volumn 26, Issue 12, 2011, Pages 1465-1470

  Higashi, Ashley ^a   Zhu, Shu ^a   Stafford, Randall S ^b   Alexander, G Caleb ^a,c,d,e  

^a UNIVERSITY OF CHICAGO   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

pharmacotherapy; primary care; respiratory disease

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; SALBUTAMOL; SALMETEROL XINAFOATE; STEROID; THEOPHYLLINE; TIOTROPIUM BROMIDE; XANTHINE DERIVATIVE;

AMBULATORY CARE; ARTICLE; ASTHMA; CONSULTATION; HEALTH SURVEY; HUMAN; MEDICAL AUDIT; NATIONAL AMBULATORY CARE SURVEY; NATIONAL DISEASE AND THERAPEUTIC INDEX; PHYSICIAN; SCORING SYSTEM; TREND STUDY;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTI-ASTHMATIC AGENTS; ASTHMA; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 83655163892     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1796-4     Document Type: Article

References (18)

1. D Getahun K Demissie GG Rhoads 2005 Recent trends in asthma hospitalization and mortality in the United States J Asthma 42 373 8 16036412 10.1081/JAS-200062995
2. American Lung Association Epidemiology and Statistics Unit. Trends in Asthma Morbidity and Mortality, February 2009.
3. R Evans 3rd DI Mullally RW Wilson, et al. 1987 National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization. and death from asthma over two decades: 1965 - 1984 Chest 91 65 74 10.1378/chest.91.6.65Sb
4. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma - -United States, 1980 - 1999. In: Surveillance Summaries, March 29, 2002.MMWR 2002;51(No. SS-1):1 - 13.
5. Center for Disease Control and Prevention, National Health Interview Survey, National Center for Health Statistics, CDC. Compiled 3/18/2008. Accessed 2/9/2010
6. National Heart, Lung and Blood Institute. Chartbook on Cardiovascular, Lung and Blood Diseases, U.S. Department of Health and Human Services. National Institute of Health 2009.
7. 2-agonists on severe asthma exacerbations and asthma-related deaths Ann Int Med 144 904 12
8. Donohue J, Fromer, L. Long-acting beta-agonists: role in asthma management. J Fam Pract. 2006 Apr;Suppl:1-6.
9. US Food and Drug Administration Website. FDA Public Health Advisory. Serevent Diskus (salmeterol xinafoate inhalation powder), Advair Diskus (fluticasone propionate & salmeterol xinafoate powder), Foradil Aerolizer (formoterol fumarate inhalation powder). Available at: http://www.fda.gov/cder/ drug/advisory/laba.htm. Accessed February 9, 2010.
10. National Heart Lung and Blood Institute. Expert Panel Report 3: guidelines for the Diagnosis and Management of Asthma. Bethesda (MD): 2007. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed February 9 2010.
11. M Schatz R Nakahiro W Crawford G Mendoza D Mosen TB Stibolt 2005 Asthma quality-of-care markers using administrative data Chest 128 1968 73 16236843 10.1378/chest.128.4.1968
12. M Schatz RS Zeiger WM Vollmer, et al. 2006 The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes Chest 130 43 50 16840381 10.1378/chest.130.1.43
13. National Ambulatory Care Medical Survey. Available at: http://www.cdc.gov/nchs/ahcd/trend-analysis.htm (Accessed June 20, 2011).
14. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Bethesda: National Heart, Lung, and Blood Institute; 2002.
15. National Asthma Education and Prevention Program: Expert Panel Report 3. Guidelines for the Diagnosis and Management of Asthma. Summary Report 2007. National Heart, Lung, and Blood Institute. NIH Publication Number #08-5846. October 2007.
16. CM Blanchette SD Culler D Ershoff B Gutierrez 2009 Association between previous health care use and initiation of inhaled corticosteroid and long acting b2 adrenergic agonis combination therapy among US patients with asthma Clin Ther 31 2574 83 20110003 10.1016/j.clinthera.2009.11.007 1:CAS:528:DC%2BC3cXhtFCjtbg%3D
17. Zell ER, McCaig LF, Kupronis BA, Besser RE, Schuchat A. A comparison of the National Disease and Therapeutic Index and the National Ambulatory Medical Care Survey to evaluate antibiotic usage. In: Proceedings of the survey research methods section, American Statistical Association (2000). Alexandria (Virginia): American Statistical Association. Available: http://www.amstat.org/ sections/srms/Proceedings/papers/2000-143.pdf. (Accessed June 20, 2011).
18. RS Stafford DC Radley 2003 The underutilization of cardiacmedications of proven benefit, 1990 to 2002 J Am Coll Cardiol 41 56 61 12570945 10.1016/S0735-1097(02)02670-0